These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 16384826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study.
    Uehara Y, Makino H, Seiki K, Urade Y, L-PGDS Clinical Research Group of Kidney.
    Nephrol Dial Transplant; 2009 Feb; 24(2):475-82. PubMed ID: 18799608
    [Abstract] [Full Text] [Related]

  • 3. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T, Tomoda F, Kinuno H, Inoue H, Takata M.
    Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
    [Abstract] [Full Text] [Related]

  • 4. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM, Lee MY, Koh JH, Park JH, Shin JY, Shin YG, Koh SB, Lee EY, Chung CH.
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus.
    Hirawa N, Uehara Y, Ikeda T, Gomi T, Hamano K, Totsuka Y, Yamakado M, Takagi M, Eguchi N, Oda H, Seiki K, Nakajima H, Urade Y.
    Nephron; 2001 Apr; 87(4):321-7. PubMed ID: 11287775
    [Abstract] [Full Text] [Related]

  • 7. De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, beta-trace, in the kidneys.
    Nagata N, Fujimori K, Okazaki I, Oda H, Eguchi N, Uehara Y, Urade Y.
    FEBS J; 2009 Dec; 276(23):7146-58. PubMed ID: 19878301
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
    Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH.
    J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
    [Abstract] [Full Text] [Related]

  • 9. Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
    Yamagishi S, Koga K, Inagaki Y, Amano S, Okamoto T, Takeuchi M.
    Drugs Exp Clin Res; 2002 Oct; 28(6):221-7. PubMed ID: 12776575
    [Abstract] [Full Text] [Related]

  • 10. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
    Yamabe N, Yokozawa T.
    J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lipocalin-type prostaglandin D synthase in urine in adriamycin-induced nephropathy of mice.
    Tsuchida T, Eguchi N, Eguchi Y, Numabe A, Nakajima H, Oda H, Seiki K, Hakamada-Taguchi R, Urade Y, Uehara Y.
    Nephron Physiol; 2004 Apr; 96(2):p42-51. PubMed ID: 14988661
    [Abstract] [Full Text] [Related]

  • 13. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E, Maekawa K, Tanimoto T, Fujisawa S, Akagi Y.
    Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 15. Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients.
    Hamano K, Totsuka Y, Ajima M, Gomi T, Ikeda T, Hirawa N, Eguchi Y, Yamakado M, Takagi M, Nakajima H, Oda H, Seiki K, Eguchi N, Urade Y, Uehara Y.
    Nephron; 2002 Sep; 92(1):77-85. PubMed ID: 12187088
    [Abstract] [Full Text] [Related]

  • 16. Abnormal autoregulation and tubuloglomerular feedback in prediabetic and diabetic OLETF rats.
    Hashimoto S, Yamada K, Kawata T, Mochizuki T, Schnermann J, Koike T.
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F598-604. PubMed ID: 19106213
    [Abstract] [Full Text] [Related]

  • 17. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Yu Y, Ohmori K, Chen Y, Sato C, Kiyomoto H, Shinomiya K, Takeuchi H, Mizushige K, Kohno M.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):904-13. PubMed ID: 15312879
    [Abstract] [Full Text] [Related]

  • 18. Adrenocortical insufficiency in Otsuka Long-Evans Tokushima Fatty rats, a type 2 diabetes mellitus model.
    Noguchi S, Ohno Y, Aoki N.
    Metabolism; 2007 Oct 18; 56(10):1326-33. PubMed ID: 17884440
    [Abstract] [Full Text] [Related]

  • 19. A low-protein diet concomitant with high calorie intake preserves renal function and structure in diabetic OLETF rats.
    Matsuda S, Iwata K, Takahashi K, Homma H, Tamura Y, Kanda Y, Inokami T, Nosaka H, Nagase M, Uchida S.
    Clin Exp Nephrol; 2004 Dec 18; 8(4):322-30. PubMed ID: 15619031
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat both before and after the onset of diabetes mellitus.
    Bajotto G, Murakami T, Nagasaki M, Tamura T, Tamura N, Harris RA, Shimomura Y, Sato Y.
    Life Sci; 2004 Sep 10; 75(17):2117-30. PubMed ID: 15312755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.